A six-year study in the United States indicated that combination therapy with pioglitazone/exenatide (twice daily)/metformin effectively reduced the incidence of high-stage liver fibrosis (7% vs
The rapid weight loss achieved with GLP-1 medications may affect nutrient absorption and overall nutritional status, potentially impacting the bodys ability to maintain healthy teeth and gums
The most common side effects in the trial included: Nausea (about 29 to 42 percent of participants, depending on the dose) Diarrhea (25 to 34 percent) Constipation (24 to 26 percent) Vomiting (11 to 25 percent) Upper respiratory tract infection (12 to 14 percent) These side effects are consistent with other injectable weight loss medications, according to Siegel
A prescription from a licensed medical doctor practicing within the USA is required for either treatment
No, it is not approved for therapeutic or clinical use
Compounded Drug Warning The FDA has not approved compounded drugs and has issued safety alerts about dosing errors, product contamination, and other quality concerns